Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11291631 Oral cannabinoid formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 29, 2017
Date of Patent
April 5, 2022
Patent Application Number
16314569
Patent Citations
‌
US Patent 10137095 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 10111840 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 10092525 Use of cannabinoids in the treatment of epilepsy
Patent Citations Received
‌
US Patent 11590087 Cannabidiol-type cannabinoid compound
‌
US Patent 11633369 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11446258 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 11963937 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11291631
Patent Primary Examiner
‌
Theodore R. Howell
CPC Code
‌
A61K 9/0095
‌
A61K 47/10
‌
A23L 27/30
‌
A23L 27/84
‌
A23L 27/86
‌
A23V 2200/16
‌
A61K 31/05
‌
A61K 9/08
‌
A61K 47/14
‌
A61K 47/44

Find more entities like US Patent 11291631 Oral cannabinoid formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.